tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Galectin Therapeutics Reveals Promising NAVIGATE Trial Results
PremiumCompany AnnouncementsGalectin Therapeutics Reveals Promising NAVIGATE Trial Results
2M ago
Galectin Therapeutics Reports Q3 2025 Financials
Premium
Company Announcements
Galectin Therapeutics Reports Q3 2025 Financials
2M ago
Promising Phase 2 Data Boosts Confidence in Galectin Therapeutics’ Belapectin for Fibrotic Disease Treatment
Premium
Ratings
Promising Phase 2 Data Boosts Confidence in Galectin Therapeutics’ Belapectin for Fibrotic Disease Treatment
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5M ago
Galectin Therapeutics Reports Reduced Losses in Q2 2025
Premium
Company Announcements
Galectin Therapeutics Reports Reduced Losses in Q2 2025
5M ago
Optimistic Buy Rating for Galectin Therapeutics Driven by Belapectin’s Potential in Treating Liver Cirrhosis and Strategic Focus
Premium
Ratings
Optimistic Buy Rating for Galectin Therapeutics Driven by Belapectin’s Potential in Treating Liver Cirrhosis and Strategic Focus
5M ago
Galectin Therapeutics announces $10M credt line from Richard Uihlein
PremiumThe FlyGalectin Therapeutics announces $10M credt line from Richard Uihlein
7M ago
Galectin Therapeutics Secures $10M Credit Line for Growth
Premium
Company Announcements
Galectin Therapeutics Secures $10M Credit Line for Growth
7M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100